TrialWorld journal of urology2017
Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY).
P Abrams et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled ittrialcites it